White Paper Download

The Benefits of On-Dose Product Security

By Barry McDonogh, Senior Vice President, Business Development

The operational challenges of the modern pharmaceutical supply-chain are well documented. Globalization and outsourcing has led to a loss of supply-chain integrity and fostered a trading environment in which illegitimate production and unauthorized distributioin is rife. While progress has been made in addressing these challenges through packaging initiatives, the maturation of on-dose identification technologies offers a speed and certainty of response to suspect-product events that has previously been unavailable to the pharmaceutical industry.

Complete the form to the right to learn more.